These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 25758273)

  • 1. Short-term rosuvastatin treatment for the prevention of contrast-induced acute kidney injury in patients receiving moderate or high volumes of contrast media: a sub-analysis of the TRACK-D study.
    Zhang J; Li Y; Tao GZ; Chen YD; Hu TH; Cao XB; Jing QM; Wang XZ; Ma YY; Wang G; Liu HW; Wang B; Xu K; Li J; Deng J; Han YL
    Chin Med J (Engl); 2015 Mar; 128(6):784-9. PubMed ID: 25758273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term rosuvastatin therapy for prevention of contrast-induced acute kidney injury in patients with diabetes and chronic kidney disease.
    Han Y; Zhu G; Han L; Hou F; Huang W; Liu H; Gan J; Jiang T; Li X; Wang W; Ding S; Jia S; Shen W; Wang D; Sun L; Qiu J; Wang X; Li Y; Deng J; Li J; Xu K; Xu B; Mehran R; Huo Y
    J Am Coll Cardiol; 2014 Jan 7-14; 63(1):62-70. PubMed ID: 24076297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Rosuvastatin on contrast-induced acute kidney injury in patients at high risk for nephropathy undergoing elective angiography.
    Abaci O; Arat Ozkan A; Kocas C; Cetinkal G; Sukru Karaca O; Baydar O; Kaya A; Gurmen T
    Am J Cardiol; 2015 Apr; 115(7):867-71. PubMed ID: 25670636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between inflammation and benefits of early high-dose rosuvastatin on contrast-induced nephropathy in patients with acute coronary syndrome: the pathophysiological link in the PRATO-ACS study (Protective Effect of Rosuvastatin and Antiplatelet Therapy on Contrast-Induced Nephropathy and Myocardial Damage in Patients With Acute Coronary Syndrome Undergoing Coronary Intervention).
    Toso A; Leoncini M; Maioli M; Tropeano F; Di Vincenzo E; Villani S; Bellandi F
    JACC Cardiovasc Interv; 2014 Dec; 7(12):1421-9. PubMed ID: 25523533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early high-dose rosuvastatin for contrast-induced nephropathy prevention in acute coronary syndrome: Results from the PRATO-ACS Study (Protective Effect of Rosuvastatin and Antiplatelet Therapy On contrast-induced acute kidney injury and myocardial damage in patients with Acute Coronary Syndrome).
    Leoncini M; Toso A; Maioli M; Tropeano F; Villani S; Bellandi F
    J Am Coll Cardiol; 2014 Jan 7-14; 63(1):71-9. PubMed ID: 24076283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early high-dose rosuvastatin and cardioprotection in the protective effect of rosuvastatin and antiplatelet therapy on contrast-induced acute kidney injury and myocardial damage in patients with acute coronary syndrome (PRATO-ACS) study.
    Leoncini M; Toso A; Maioli M; Tropeano F; Badia T; Villani S; Bellandi F
    Am Heart J; 2014 Nov; 168(5):792-7. PubMed ID: 25440809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins for the prevention of contrast-induced acute kidney injury.
    Ball T; McCullough PA
    Nephron Clin Pract; 2014; 127(1-4):165-71. PubMed ID: 25343843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rosuvastatin Treatment for Preventing Contrast-Induced Acute Kidney Injury After Cardiac Catheterization: A Meta-Analysis of Randomized Controlled Trials.
    Yang Y; Wu YX; Hu YZ
    Medicine (Baltimore); 2015 Jul; 94(30):e1226. PubMed ID: 26222855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term rosuvastatin therapy prevents contrast-induced acute kidney injury in female patients with diabetes and chronic kidney disease: a subgroup analysis of the TRACK-D study.
    Li J; Li Y; Xu B; Jia G; Guo T; Wang D; Xu K; Deng J; Han Y
    J Thorac Dis; 2016 May; 8(5):1000-6. PubMed ID: 27162677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous hydration (with or without rosuvastatin) should remain the cornerstone of the prevention of contrast-induced acute kidney injury in patients with diabetes and chronic kidney disease.
    Cecere N; Jadoul M; Labriola L
    J Am Coll Cardiol; 2014 Jul; 64(3):332. PubMed ID: 25034074
    [No Abstract]   [Full Text] [Related]  

  • 11. [Role of probucol in preventing contrast induced acute kidney injury after coronary interventional procedure: a randomized trial].
    Yin L; Li GP; Liu T; Liu HM; Chen X; He M; Zheng XT; Liu EZ; Zhou LJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 May; 37(5):385-8. PubMed ID: 19781209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reply: Intravenous hydration (with or without rosuvastatin) should remain the cornerstone of the prevention of contrast-induced acute kidney injury in patients with diabetes and chronic kidney disease.
    Han Y
    J Am Coll Cardiol; 2014 Jul; 64(3):332-3. PubMed ID: 25034073
    [No Abstract]   [Full Text] [Related]  

  • 13. Rosuvastatin may reduce the incidence of cardiovascular events in patients with acute coronary syndromes receiving percutaneous coronary intervention by suppressing miR-155/SHIP-1 signaling pathway.
    Xie W; Li P; Wang Z; Chen J; Lin Z; Liang X; Mo Y
    Cardiovasc Ther; 2014 Dec; 32(6):276-82. PubMed ID: 25319951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do statins reduce the risk of contrast-induced acute kidney injury in patients undergoing coronary angiography or percutaneous coronary interventions?
    Alpert MA
    J Am Coll Cardiol; 2014 Jan 7-14; 63(1):80-2. PubMed ID: 24076280
    [No Abstract]   [Full Text] [Related]  

  • 15. Statins and contrast-induced acute kidney injury with coronary angiography.
    Gandhi S; Mosleh W; Abdel-Qadir H; Farkouh ME
    Am J Med; 2014 Oct; 127(10):987-1000. PubMed ID: 24852935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of high-dose rosuvastatin loading before percutaneous coronary intervention in female patients with non-ST-segment elevation acute coronary syndrome.
    Gao Y; Jia ZM; Sun YJ; Zhang ZH; Ren LN; Qi GX
    Chin Med J (Engl); 2012 Jul; 125(13):2250-4. PubMed ID: 22882843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
    Strandberg TE; Feely J; Sigurdsson EL;
    Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast-induced acute kidney injury following coronary angiography: a cohort study of hospitalized patients with or without chronic kidney disease.
    Neyra JA; Shah S; Mooney R; Jacobsen G; Yee J; Novak JE
    Nephrol Dial Transplant; 2013 Jun; 28(6):1463-71. PubMed ID: 23585585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The PRATO-ACS study].
    Marenzi G; Briguori C
    G Ital Cardiol (Rome); 2013 Dec; 14(12):803-8. PubMed ID: 24336595
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevention: Rosuvastatin can prevent contrast-induced AKI.
    Roberts A
    Nat Rev Cardiol; 2013 Dec; 10(12):679. PubMed ID: 24165911
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.